Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Invested Capital (2020 - 2025)

Biofrontera (BFRI) has 6 years of Invested Capital data on record, last reported at -$2.6 million in Q3 2025.

  • For Q3 2025, Invested Capital fell 146.67% year-over-year to -$2.6 million; the TTM value through Sep 2025 reached -$2.6 million, down 146.67%, while the annual FY2024 figure was $4.4 million, 49.03% down from the prior year.
  • Invested Capital reached -$2.6 million in Q3 2025 per BFRI's latest filing, up from -$4.7 million in the prior quarter.
  • Across five years, Invested Capital topped out at $30.8 million in Q4 2022 and bottomed at -$17.4 million in Q3 2021.
  • Average Invested Capital over 5 years is $7.8 million, with a median of $7.2 million recorded in 2023.
  • Peak YoY movement for Invested Capital: surged 1359.72% in 2022, then plummeted 146.67% in 2025.
  • A 5-year view of Invested Capital shows it stood at $14.6 million in 2021, then skyrocketed by 111.39% to $30.8 million in 2022, then plummeted by 71.78% to $8.7 million in 2023, then tumbled by 49.03% to $4.4 million in 2024, then plummeted by 158.22% to -$2.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were -$2.6 million in Q3 2025, -$4.7 million in Q2 2025, and $500000.0 in Q1 2025.